Antimicrobial allergies and cross-reactivity

Beta-Lactam Allergy - Penicillin's Pesky Problem

• Most severe reactions are Type I (IgE-mediated), causing urticaria, angioedema, or anaphylaxis.
• Cross-reactivity is driven by R-group side-chain similarity, not the core beta-lactam structure.
  • Penicillin → Cephalosporins: Low risk (<2%), mainly with 1st/2nd-gen agents (e.g., amoxicillin & cefadroxil).
  • Penicillin → Carbapenems: Very low risk (<1%).

⭐ Aztreonam (a monobactam) is safe in penicillin-allergic patients as it lacks cross-reactivity. The exception is cross-reactivity with ceftazidime, which shares an identical side chain.

Allergy Workup - Scratching The Surface

• Goal: Confirm or refute a patient-reported IgE-mediated (Type I) allergy, especially for penicillins, to enable optimal antibiotic selection.
• Initial Step: Detailed history to assess reaction type (e.g., anaphylaxis vs. delayed rash) and timing.

• Penicillin Skin Testing (PST):
  • Detects IgE antibodies to penicillin determinants.
  • High negative predictive value (>97%); a negative test effectively rules out an immediate allergy.
• Drug Provocation Test (DPT):
  • The gold standard; involves a graded challenge with the actual drug.

⭐ Over 90% of patients with a self-reported penicillin allergy are found to be negative on formal testing and can tolerate penicillins.

Cross-Reactivity - All In The Family?

• True IgE-mediated penicillin (PCN) allergy is rare. Most reported histories are not clinically significant contraindications.
• Cross-reactivity risk is dictated by R-group side chain similarity, not the core β-lactam ring.
  • PCN → Cephalosporins: Low risk (<2%), especially with 3rd/4th gen agents having dissimilar side chains.
  • PCN → Carbapenems: Very low risk (<1%).

⭐ Aztreonam (a monobactam) has virtually no cross-reactivity with other β-lactams, making it a safe choice in severe PCN-allergic patients. The sole exception is ceftazidime, which shares an identical side chain.

Other Allergies - Beyond The Beta-Lactams

• Sulfonamides (e.g., TMP-SMX):

  • High incidence of delayed hypersensitivity reactions (e.g., morbilliform rash).
  • Mechanism involves reactive metabolites, not direct IgE action.
  • ⚠️ Severe risk of Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN).
  • Cross-reactivity with non-antibiotic sulfonamides (loops, sulfonylureas) is low but possible.

• Vancomycin:

  • Red Man Syndrome: A rate-dependent infusion reaction causing flushing and pruritus due to direct mast cell degranulation. Not a true IgE-mediated allergy.
  • Manage by slowing infusion and pre-medicating with antihistamines.

⭐ SJS/TEN are severe, life-threatening mucocutaneous reactions. Suspect them in any patient on a high-risk drug (especially sulfonamides) who develops fever, mucosal lesions, and a spreading purpuric rash.

High‑Yield Points - ⚡ Biggest Takeaways

• Penicillin allergy is the most common drug allergy; Type I (IgE-mediated) reactions are the most severe.
• Penicillin-cephalosporin cross-reactivity is low (<1%), especially with later generations due to dissimilar R-group side chains.
• Aztreonam has no cross-reactivity with other beta-lactams, making it a safe alternative in penicillin allergy.
• Sulfonamide allergies are linked to severe skin reactions like Stevens-Johnson syndrome (SJS).
• Vancomycin can cause Red Man Syndrome, an infusion reaction, not a true IgE-mediated allergy.